TickerFactsScreenerDevelopers

Theravance Biopharma, Inc. (TBPH) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$168.86M2016: -$98.99M2017: -$201.05M2018: -$112.87M2019: -$238.20M2020: -$250.40M2021: -$207.86M2022: -$186.99M2023: -$27.00M2024: -$11.54M2025: $238.54M$238.54M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$238.54M+2168.0%
2024-$11.54M+57.3%
2023-$27.00M+85.6%
2022-$186.99M+10.0%
2021-$207.86M+17.0%
2020-$250.40M-5.1%
2019-$238.20M-111.0%
2018-$112.87M+43.9%
2017-$201.05M-103.1%
2016-$98.99M+41.4%
2015-$168.86M—